ST-segment elevation myocardial infarction are at a higher risk of bleeding than whites. 3 Although similar results were noted in Asian patients with non-ST-segment elevation myocardial infarction (NSTEMI) using registry data from 2003 to 2005, 4 characteristics of contemporary NSTEMI cohort and their bleeding risks may differ following advancements in troponin assays, changes in definition of myocardial infarction, and adoption of newer antiplatelet agents. In this context, we sought to reinvestigate the impact of Asian ethnicity on bleeding in a contemporary NSTEMI cohort.
We analyzed the Nationwide Inpatient Sample database, a part of the Healthcare Cost and Utilization Project from the Agency for Healthcare Research and Quality, 5 and identified all patients older than 18 years who were hospitalized with a primary diagnosis of NSTEMI (International Classification of Diseases diagnosis code 410.7x) between 2010 and 2014. The institutional review board of our facility determined that this study was exempted from formal review. The exclusion criteria, codes used to identify comorbidities and outcomes, and covariates included in multivariate models (except for systemic thrombolysis) were identical to our prior study. 3 The primary outcome was in-hospital major bleeding, defined as a composite of intracranial hemorrhage and blood transfusion for bleeding events. All statistical analyses were performed with SPSS version 24.0 (IBM Corp, Armonk, New York).
Data on race were missing in 7.9% of the population. After exclusions, 285 076 white and 8608 Asian patients were included. Hypertension, diabetes, renal failure, anemia, and cardiogenic shock were more commonly observed in Asians, while obesity was less prevalent (Table 1) . Asian patients had a higher incidence of major bleeding (4.9% vs 3.4%; P < .001), and similar findings were noted in each individual component of the primary end point (intracranial hemorrhage and blood transfusion for bleeding events; Table 1 ). No significant difference was seen in in-hospital mortality (4.2% vs 4.0%; P ¼ .24). After adjusting for clinical and nonclinical variables, Asian ethnicity was an independent predictor for major bleeding in the overall cohort (odds ratio: 1.25; 95% confidence interval: 1.12-1.39; P < .001) and in all subgroups stratified by treatment strategy (percutaneous coronary intervention, coronary artery bypass graft, and medical therapy). Our present study confirmed Asian ethnicity as an independent predictor for major bleeding in a contemporary NSTEMI cohort. The differences in demographics and risk factors, such as higher prevalence of renal failure or low body mass index, probably contribute to the higher risk of bleeding observed in Asians. 1, 2, 6, 7 In addition, several studies suggested that Asians respond differently to antiplatelets or anticoagulants. 8, 9 This increased risk of bleeding would warrant further investigation of optimal treatment strategies tailored for Asian patients. Finally, the limitations of the study noted in our prior publication also apply to the current analysis. 3 
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